Back to top
more

AdaptHealth (AHCO)

(Delayed Data from NSDQ)

$9.58 USD

9.58
469,020

-0.20 (-2.04%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $9.59 +0.01 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (150 out of 251)

Industry: Medical - Products

Better trading starts here.

Balance Sheet

Research for AHCO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for AdaptHealth Corp falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 77 46 150 100 77
Receivables 389 359 360 171 79
Notes Receivable 0 0 0 0 0
Inventories 114 128 123 59 13
Other Current Assets 69 52 37 33 13
Total Current Assets 649 585 670 363 181
Net Property & Equipment 495 487 399 110 64
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 346 282 304 208 28
Intangibles 2,855 3,708 3,715 1,115 267
Deposits & Other Assets 21 22 15 16 7
Total Assets 4,509 5,220 5,250 1,813 546
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 37 0
Accounts Payable 392 338 358 254 103
Current Portion Long-Term Debt 53 35 20 8 2
Current Portion Capital Leases 9 2 15 22 20
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 53 52 75 101 27
Total Current Liabilities 537 456 500 422 151
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 2,095 2,153 2,184 777 395
Non-Current Capital Leases 23 4 0 34 0
Other Non-Current Liabilities 302 344 380 186 29
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 3,042 3,062 3,184 1,419 575
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,150 2,130 2,107 514 11
Retained Earnings -653 26 -43 -91 -27
Other Equity 13 15 2 -28 -13
Treasury Stock 43 14 0 0 0
Total Shareholder's Equity 1,467 2,158 2,067 395 -29
Total Liabilities & Shareholder's Equity 4,509 5,220 5,250 1,813 546
Total Common Equity 1,467 2,158 2,067 395 -29
Shares Outstanding 132.60 134.70 133.80 89.60 40.30
Book Value Per Share 11.06 16.02 15.45 4.41 -0.73

Fiscal Year End for AdaptHealth Corp falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 77 56 45 101
Receivables NA 389 371 366 353
Notes Receivable NA 0 0 0 0
Inventories NA 114 116 115 136
Other Current Assets NA 69 42 43 56
Total Current Assets NA 649 585 568 647
Net Property & Equipment NA 495 490 504 503
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 346 319 280 285
Intangibles NA 2,855 3,177 3,695 3,698
Deposits & Other Assets NA 21 23 22 20
Total Assets NA 4,509 4,725 5,203 5,283
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 392 314 338 401
Current Portion Long-Term Debt NA 53 40 40 40
Current Portion Capital Leases NA 9 6 4 30
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 53 59 46 51
Total Current Liabilities NA 537 448 458 524
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 2,095 2,127 2,136 2,169
Non-Current Capital Leases NA 23 16 11 5
Other Non-Current Liabilities NA 309 318 319
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 3,042 2,985 3,016 3,116
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 2,150 2,145 2,140 2,135
Retained Earnings NA -653 -398 56 42
Other Equity NA 13 16 14 13
Treasury Stock NA 43 23 23 23
Total Shareholder's Equity NA 1,467 1,740 2,187 2,167
Total Liabilities & Shareholder's Equity NA 4,509 4,725 5,203 5,283
Total Common Equity 0 1,467 1,740 2,187 2,167
Shares Outstanding 132.90 132.60 134.90 134.50 134.10
Book Value Per Share 0.00 11.06 12.90 16.26 16.16